These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 7644541)
1. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Mukherji B; Chakraborty NG; Yamasaki S; Okino T; Yamase H; Sporn JR; Kurtzman SK; Ergin MT; Ozols J; Meehan J Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8078-82. PubMed ID: 7644541 [TBL] [Abstract][Full Text] [Related]
2. Presentation of synthetic peptide antigen encoded by the MAGE-1 gene by granulocyte/macrophage-colony-stimulating-factor-cultured macrophages from HLA-A1 melanoma patients. Yamasaki S; Okino T; Chakraborty NG; Adkisson WO; Sampieri A; Padula SJ; Mauri F; Mukherji B Cancer Immunol Immunother; 1995 Apr; 40(4):268-71. PubMed ID: 7750125 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine. Hu X; Chakraborty NG; Sporn JR; Kurtzman SH; Ergin MT; Mukherji B Cancer Res; 1996 Jun; 56(11):2479-83. PubMed ID: 8653680 [TBL] [Abstract][Full Text] [Related]
4. Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Salgaller ML; Weber JS; Koenig S; Yannelli JR; Rosenberg SA Cancer Immunol Immunother; 1994 Aug; 39(2):105-16. PubMed ID: 7519125 [TBL] [Abstract][Full Text] [Related]
5. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis. Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095 [TBL] [Abstract][Full Text] [Related]
6. Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma. Chakraborty NG; Chattopadhyay S; Mehrotra S; Chhabra A; Mukherji B Hum Immunol; 2004 Aug; 65(8):794-802. PubMed ID: 15336780 [TBL] [Abstract][Full Text] [Related]
7. Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro. Tjandrawan T; Martin DM; Maeurer MJ; Castelli C; Lotze MT; Storkus WJ J Immunother; 1998 Mar; 21(2):149-57. PubMed ID: 9551367 [TBL] [Abstract][Full Text] [Related]
8. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. Traversari C; van der Bruggen P; Luescher IF; Lurquin C; Chomez P; Van Pel A; De Plaen E; Amar-Costesec A; Boon T J Exp Med; 1992 Nov; 176(5):1453-7. PubMed ID: 1402688 [TBL] [Abstract][Full Text] [Related]
12. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Salgaller ML; Afshar A; Marincola FM; Rivoltini L; Kawakami Y; Rosenberg SA Cancer Res; 1995 Nov; 55(21):4972-9. PubMed ID: 7585538 [TBL] [Abstract][Full Text] [Related]
13. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition. Stevens EJ; Jacknin L; Robbins PF; Kawakami Y; el Gamil M; Rosenberg SA; Yannelli JR J Immunol; 1995 Jan; 154(2):762-71. PubMed ID: 7814882 [TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s). Imro MA; Manici S; Russo V; Consogno G; Bellone M; Rugarli C; Traversari C; Protti MP Cancer Res; 1999 May; 59(10):2287-91. PubMed ID: 10344730 [TBL] [Abstract][Full Text] [Related]
15. A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules. Luiten RM; Demotte N; Tine J; van der Bruggen P Tissue Antigens; 2000 Jul; 56(1):77-81. PubMed ID: 10958359 [TBL] [Abstract][Full Text] [Related]
16. Perspectives for immunization of HLA-A1 patients carrying a malignant melanoma expressing gene MAGE-1. Marchand M; Brasseur F; van der Bruggen P; Coulie P; Boon T Dermatology; 1993; 186(4):278-80. PubMed ID: 8513199 [TBL] [Abstract][Full Text] [Related]
17. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423 [TBL] [Abstract][Full Text] [Related]
18. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. Rivoltini L; Kawakami Y; Sakaguchi K; Southwood S; Sette A; Robbins PF; Marincola FM; Salgaller ML; Yannelli JR; Appella E J Immunol; 1995 Mar; 154(5):2257-65. PubMed ID: 7868898 [TBL] [Abstract][Full Text] [Related]
19. A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12. Panelli MC; Bettinotti MP; Lally K; Ohnmacht GA; Li Y; Robbins P; Riker A; Rosenberg SA; Marincola FM J Immunol; 2000 Apr; 164(8):4382-92. PubMed ID: 10754339 [TBL] [Abstract][Full Text] [Related]
20. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines. Fenton RG; Turcovski-Corrales SM; Taub DD J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]